Skip to content

Endoscopic Evaluation After Esophagectomy

Endoscopic Evaluation for the Postoperative Condition After Esophagectomy and Reconstruction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02703142
Enrollment
10
Registered
2016-03-09
Start date
2015-10-31
Completion date
2016-10-31
Last updated
2016-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomotic Leak, Constriction, Esophageal Neoplasms, Ischemia

Keywords

esophagogastrostomy, gastric conduit ischemia, endoscopy

Brief summary

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

Detailed description

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. However the evaluation and prevention before developing gastric conduit ischemia have been established. The investigators have built a hypothesis that the evaluation for gastric mucosal ischemia in early phase after esophagectomy predict the complication of gastric conduit. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

Interventions

postoperative endoscopic evaluation

Sponsors

Nagasaki University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 84 Years
Healthy volunteers
No

Inclusion criteria

* Malignant or end-stage benign esophageal disease. * Esophagectomy with reconstruction by a gastric pull-up.

Exclusion criteria

* Severe heart failure and pulmonary dysfunction * Severe renal and liver dysfunction * Allergenic history * Pregnancy

Design outcomes

Primary

MeasureTime frame
Number of participants with endoscopy-related adverse events as assessed by Clavien-Dindo ClassificationFrom 1 to 29 days after esophagectomy
Number of participants with the classification of gastric conduit ischemia by endoscopic findingsFrom 1 to 15 days after esophagectomy
Number of participants with the major complications of gastric conduit (strictures, leakage, necrosis)From 1 to 29 days after esophagectomy

Secondary

MeasureTime frameDescription
Biological examination of the mucosal biopsy of gastric conduit as assessed by the ischemia related RNA copy numberFrom 1 to 29 days after esophagectomy
Biological examination of the mucosal biopsy of gastric conduit as assessed by the scoring system for immunohistochemical stainingFrom 1 to 29 days after esophagectomyThe scoring system refer to the article entitled a scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group (J Clin Pathol. 1997 Oct; 50(10): 801-804.)
Biological examination of gastric conduit as assessed by the Mitochondrial DNA copy numberFrom 1 to 29 days after esophagectomy

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026